Remember the first time you used a smartphone? That moment when you realized that complex computing had become as simple as ...

CEO Mike Morrissey highlighted significant momentum in 2024, emphasizing the company's goal of achieving $3 billion in annual cabozantinib (Cabo) revenue by 2030 and $5 billion for zanzalintinib ...